Debbie P. Drane
Debbie P. Drane has been with CSL in the R&D Division for over 25 years. During this time, she has had a number of roles and have substantial experience in most areas of vaccine development. In particular, she has worked on CSL’s proprietary ISCOMATRIX adjuvant for many years in both technical and management positions playing a key role in the successful development of the technology. As the SVP R&D reporting to the CSO, she is responsible for all activities related to the ISCOMATRIX adjuvant technology including research, manufacturing, and commercialization as well as maintaining successful relationships with major partners of the technology such as Merck and Pfizer. She completed her scientific training at the University of Melbourne majoring in immunology.
Biography Updated on 1 June 2011